Pub Date : 2025-04-07DOI: 10.1080/1354750X.2025.2475474
Mille Kirk, Josephine R Ekmann, Martin Overgaard, Charlotte K Ekelund, Hanne K Hegaard, Line Rode
Background: Preterm prelabor rupture of the fetal membranes (PPROM) increases the risk of neonatal mortality and morbidity. The etiology behind the condition is multifactorial but believed to result from an overactivation of inflammatory pathways. This systematic review aimed to synthesize the literature behind first-trimester biomarkers associated with PPROM and compare it to literature within the same area for preterm birth.
Methods: A search strategy was performed in PubMed, Embase, and CINAHL from 1993 to 2024 resulting in 14,889 articles screened by two independent authors and presented according to PRISMA guidelines. The biomarkers from the included articles were categorized into four medical headings: The immune system, metabolism and endocrinology, hematology, and reproduction.
Results: Biomarkers associated with PPROM were primarily related to the immune system. C-reactive protein (CRP) and white blood cells (WBC) were often investigated for an association with PPROM but displayed divergent results of varying quality. Decreased concentrations of placental growth factor (PlGF) were associated with PPROM and spontaneous preterm birth, potentially highlighting a shared etiology, making soluble fms-like tyrosine kinase-1 (sFlt-1) interesting to investigate as well.
Conclusion: Most biomarkers were examined in single studies, providing limited data to make significant conclusions about each biomarker. This review encourages further investigation of CRP, WBC, PlGF, and sFlt-1.
{"title":"A systematic review of first-trimester blood biomarkers associated with preterm prelabor rupture of the fetal membranes.","authors":"Mille Kirk, Josephine R Ekmann, Martin Overgaard, Charlotte K Ekelund, Hanne K Hegaard, Line Rode","doi":"10.1080/1354750X.2025.2475474","DOIUrl":"10.1080/1354750X.2025.2475474","url":null,"abstract":"<p><p><b>Background:</b> Preterm prelabor rupture of the fetal membranes (PPROM) increases the risk of neonatal mortality and morbidity. The etiology behind the condition is multifactorial but believed to result from an overactivation of inflammatory pathways. This systematic review aimed to synthesize the literature behind first-trimester biomarkers associated with PPROM and compare it to literature within the same area for preterm birth.</p><p><p><b>Methods:</b> A search strategy was performed in PubMed, Embase, and CINAHL from 1993 to 2024 resulting in 14,889 articles screened by two independent authors and presented according to PRISMA guidelines. The biomarkers from the included articles were categorized into four medical headings: The immune system, metabolism and endocrinology, hematology, and reproduction.</p><p><p><b>Results:</b> Biomarkers associated with PPROM were primarily related to the immune system. C-reactive protein (CRP) and white blood cells (WBC) were often investigated for an association with PPROM but displayed divergent results of varying quality. Decreased concentrations of placental growth factor (PlGF) were associated with PPROM and spontaneous preterm birth, potentially highlighting a shared etiology, making soluble fms-like tyrosine kinase-1 (sFlt-1) interesting to investigate as well.</p><p><p><b>Conclusion:</b> Most biomarkers were examined in single studies, providing limited data to make significant conclusions about each biomarker. This review encourages further investigation of CRP, WBC, PlGF, and sFlt-1.</p>","PeriodicalId":8921,"journal":{"name":"Biomarkers","volume":" ","pages":"1-13"},"PeriodicalIF":2.0,"publicationDate":"2025-04-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143571956","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-04-06DOI: 10.1080/1354750X.2025.2485142
Mengmeng Dong, Jinna Zhang, Li Yang, Yi Li, Jingsong He, Zhen Cai
Purpose: Multiple myeloma (MM) is a terminally differentiated plasma cell hematological malignancy. The revised international staging system (RISS) is commonly used in patients with de novo MM, but it has limitations in predicting prognosis. Better biomarkers need to added to the staging system.
Results: This retrospective study included a total of 302 patients. Smooth curve fitting analysis showed that serum ferritin levels were associated with relapse and all-cause death. The K-M curve analysis indicated that MM patients with higher ferritin levels had shorter PFS (P < 0.0056) and OS (P = 0.0014). Multivariate Cox regression analysis also showed MM patients with high serum ferritin had poor PFS (P = 0.0012) and OS (P = 0.0258), with independent correlation. The prediction model of ROC analysis based on Cox regression validated ferritin had a predictive value for PFS and OS, and increased the predictive value of ISS and RISS for OS.s.
Conclusion: We revealed that baseline serum ferritin levels were associated with prognosis in patients with MM, and patients with higher serum ferritin have poorer PFS and OS. Serum ferritin could increase the prediction value. The study provided a new ecidence for searching for prognostic biomarkers in MM patients.
{"title":"Serum ferritin can serve as a biomarker for the prognosis and increased the prognostic predictive value of ISS/RISS in multiple myeloma patients.","authors":"Mengmeng Dong, Jinna Zhang, Li Yang, Yi Li, Jingsong He, Zhen Cai","doi":"10.1080/1354750X.2025.2485142","DOIUrl":"https://doi.org/10.1080/1354750X.2025.2485142","url":null,"abstract":"<p><strong>Purpose: </strong>Multiple myeloma (MM) is a terminally differentiated plasma cell hematological malignancy. The revised international staging system (RISS) is commonly used in patients with de novo MM, but it has limitations in predicting prognosis. Better biomarkers need to added to the staging system.</p><p><strong>Results: </strong>This retrospective study included a total of 302 patients. Smooth curve fitting analysis showed that serum ferritin levels were associated with relapse and all-cause death. The K-M curve analysis indicated that MM patients with higher ferritin levels had shorter PFS (<i>P</i> < 0.0056) and OS (<i>P</i> = 0.0014). Multivariate Cox regression analysis also showed MM patients with high serum ferritin had poor PFS (<i>P</i> = 0.0012) and OS (<i>P</i> = 0.0258), with independent correlation. The prediction model of ROC analysis based on Cox regression validated ferritin had a predictive value for PFS and OS, and increased the predictive value of ISS and RISS for OS.s.</p><p><strong>Conclusion: </strong>We revealed that baseline serum ferritin levels were associated with prognosis in patients with MM, and patients with higher serum ferritin have poorer PFS and OS. Serum ferritin could increase the prediction value. The study provided a new ecidence for searching for prognostic biomarkers in MM patients.</p>","PeriodicalId":8921,"journal":{"name":"Biomarkers","volume":" ","pages":"1-13"},"PeriodicalIF":2.0,"publicationDate":"2025-04-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143794663","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-04-04DOI: 10.1080/1354750X.2025.2489453
Tonima Rahman Tuli, Mijan Mia, Ahsan Habib
Adrenocortical carcinoma (ACC) is a rare and extremely lethal endocrine malignancy emerging from adrenal cortex, characterized by a poor prognosis. This study, performed integrated bioinformatics to elucidate the underlying molecular mechanisms and identify novel biomarkers, validating them as therapeutic targets for ACC prognosis. The RNA-seq data across five gene expression profiles identified 79 DEGs through a comparative analysis of normal and ACC specimens. Functional enrichment and pathway analyses using the DAVID database revealed the most significant GO terms and enriched KEGG pathways. PPI network was constructed utilizing the STRING database, followed by module analysis in Cytoscape. Finally, 10 hub genes were identified including TAGLN, LUM, PDGFRA, FBLN5, MMP2, LAMA2, DCN, IGF1, FBLN1 and CXCL12 as potential biomarkers. Subsequent survival analysis confirmed that TAGLN, LUM, LAMA2, FBLN5 and FBLN1 are significantly associated with poor patient survivability. Furthermore, TFs-DEGs and miRNAs-DEGs network analyses, identified 10 transcriptional and post-translational regulators. Finally, gene-disease and gene-drug association, highlighted correlated diseases and their promising inhibitors. In conclusion, the identified novel biomarkers and associated pathways, provides a comprehensive insight into the molecular mechanisms, prognosis, and potential clinical applications for the diagnosis and therapeutic interventions of ACC.
{"title":"Integrated bioinformatics approach for the identification and validation of novel biomarkers in ACC progression and prognosis.","authors":"Tonima Rahman Tuli, Mijan Mia, Ahsan Habib","doi":"10.1080/1354750X.2025.2489453","DOIUrl":"https://doi.org/10.1080/1354750X.2025.2489453","url":null,"abstract":"<p><p>Adrenocortical carcinoma (ACC) is a rare and extremely lethal endocrine malignancy emerging from adrenal cortex, characterized by a poor prognosis. This study, performed integrated bioinformatics to elucidate the underlying molecular mechanisms and identify novel biomarkers, validating them as therapeutic targets for ACC prognosis. The RNA-seq data across five gene expression profiles identified 79 DEGs through a comparative analysis of normal and ACC specimens. Functional enrichment and pathway analyses using the DAVID database revealed the most significant GO terms and enriched KEGG pathways. PPI network was constructed utilizing the STRING database, followed by module analysis in Cytoscape. Finally, 10 hub genes were identified including TAGLN, LUM, PDGFRA, FBLN5, MMP2, LAMA2, DCN, IGF1, FBLN1 and CXCL12 as potential biomarkers. Subsequent survival analysis confirmed that TAGLN, LUM, LAMA2, FBLN5 and FBLN1 are significantly associated with poor patient survivability. Furthermore, TFs-DEGs and miRNAs-DEGs network analyses, identified 10 transcriptional and post-translational regulators. Finally, gene-disease and gene-drug association, highlighted correlated diseases and their promising inhibitors. In conclusion, the identified novel biomarkers and associated pathways, provides a comprehensive insight into the molecular mechanisms, prognosis, and potential clinical applications for the diagnosis and therapeutic interventions of ACC.</p>","PeriodicalId":8921,"journal":{"name":"Biomarkers","volume":" ","pages":"1-21"},"PeriodicalIF":2.0,"publicationDate":"2025-04-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143778877","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-03-23DOI: 10.1080/1354750X.2025.2481407
Alan H B Wu
{"title":"The ischaemia-modified albumin test: new tricks for an old dog?","authors":"Alan H B Wu","doi":"10.1080/1354750X.2025.2481407","DOIUrl":"10.1080/1354750X.2025.2481407","url":null,"abstract":"","PeriodicalId":8921,"journal":{"name":"Biomarkers","volume":" ","pages":"1-2"},"PeriodicalIF":2.0,"publicationDate":"2025-03-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143655813","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-03-19DOI: 10.1080/1354750X.2025.2473724
Diarmuid Daniels, Davood Roshan, Nathan A Lewis, John Newell, Georgie Bruinvels, Paul Catterson, Jamie Harley, Micheal Newell, Andrew Barr, Charles R Pedlar
Blood biomarkers can provide objective insight into a player's physiological state of recovery. Individualised approaches to biomarker monitoring may be of higher potential value in assessing player health and recovery compared to population-based reference ranges. We aimed to explore the application of individualised adaptive reference ranges (IARR) in English Premier League (EPL) soccer players using a POC biomarker for C-Reactive Protein (CRP) as a marker of inflammation. Using historical data collected from players' CRP values during the 2019-2020 season, we evaluated the effectiveness of static and IARR in identifying abnormal values and reported sensitivity and specificity at a 5% significance level. Our analysis confirmed that monitoring with IARR is more effective in identifying true abnormalities compared to population-based static reference ranges, particularly when the intra-individual variability is considerably lower than inter-individual variability. The application of IARR for blood monitoring data could assist the practitioner in identifying periods where a player may require performance (e.g. workload management and recovery practices) or medical support from the multi-disciplinary team. However, IARR serve more as an early warning system than a diagnostic tool. Thus, significant care is needed to prevent misuse and misinterpretation when implementing this strategy in real-world settings.
{"title":"Early warning system for player recovery? A series of case studies illustrating the application of individualised adaptive reference ranges in the longitudinal blood monitoring of English Premier League soccer players.","authors":"Diarmuid Daniels, Davood Roshan, Nathan A Lewis, John Newell, Georgie Bruinvels, Paul Catterson, Jamie Harley, Micheal Newell, Andrew Barr, Charles R Pedlar","doi":"10.1080/1354750X.2025.2473724","DOIUrl":"10.1080/1354750X.2025.2473724","url":null,"abstract":"<p><p>Blood biomarkers can provide objective insight into a player's physiological state of recovery. Individualised approaches to biomarker monitoring may be of higher potential value in assessing player health and recovery compared to population-based reference ranges. We aimed to explore the application of individualised adaptive reference ranges (IARR) in English Premier League (EPL) soccer players using a POC biomarker for C-Reactive Protein (CRP) as a marker of inflammation. Using historical data collected from players' CRP values during the 2019-2020 season, we evaluated the effectiveness of static and IARR in identifying abnormal values and reported sensitivity and specificity at a 5% significance level. Our analysis confirmed that monitoring with IARR is more effective in identifying true abnormalities compared to population-based static reference ranges, particularly when the intra-individual variability is considerably lower than inter-individual variability. The application of IARR for blood monitoring data could assist the practitioner in identifying periods where a player may require performance (e.g. workload management and recovery practices) or medical support from the multi-disciplinary team. However, IARR serve more as an early warning system than a diagnostic tool. Thus, significant care is needed to prevent misuse and misinterpretation when implementing this strategy in real-world settings.</p>","PeriodicalId":8921,"journal":{"name":"Biomarkers","volume":" ","pages":"1-14"},"PeriodicalIF":2.0,"publicationDate":"2025-03-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143514643","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-03-19DOI: 10.1080/1354750X.2025.2479664
Hiba A Yousif, Mohammed A Hami
Background and objective: Waterpipe smoking (WPS) has increased globally and may lead to various metabolic disorders. However, its long-term effects and cessation impact on metabolic biomarkers and omentin-1 remain unclear. This study aims to evaluate the impact of WPS and its cessation on metabolic biomarkers and omentin-1 levels and explore their correlations.
Materials and methods: 90 individuals were categorized into three groups (non-smokers, waterpipe smokers and cessation of waterpipe smokers). FBS and lipid profiles including TC, TG and HDL were measured using the Cobas 6000 c501 system, while FI was analyzed with the Cobas 6000 c601 system. Omentin-1 concentrations were determined using the enzyme-linked immunosorbent assay (ELISA) with a human omentin ELISA kit.
Results: FI, HOMA-IR and lipid profiles were significantly elevated in WPS and cessation groups. Omentin-1 and DBP levels significantly decreased in both groups compared to non-smokers. Increased WPS duration leads to reduced BMI, WC and DBP, while cessation duration decreases FBS and SBP. A negative association was identified among omentin-1 with FBS and O2.
Conclusion: WPS and its cessation adversely affect metabolic health, reducing omentin-1 levels and increasing the risk of metabolic disorders. Over time, cessation improves specific biochemical markers, highlighting the need for public health awareness.
{"title":"Effect of waterpipe smoking and its cessation on metabolic biomarkers and a novel biomarker omentin-1.","authors":"Hiba A Yousif, Mohammed A Hami","doi":"10.1080/1354750X.2025.2479664","DOIUrl":"10.1080/1354750X.2025.2479664","url":null,"abstract":"<p><strong>Background and objective: </strong>Waterpipe smoking (WPS) has increased globally and may lead to various metabolic disorders. However, its long-term effects and cessation impact on metabolic biomarkers and omentin-1 remain unclear. This study aims to evaluate the impact of WPS and its cessation on metabolic biomarkers and omentin-1 levels and explore their correlations.</p><p><strong>Materials and methods: </strong>90 individuals were categorized into three groups (non-smokers, waterpipe smokers and cessation of waterpipe smokers). FBS and lipid profiles including TC, TG and HDL were measured using the Cobas 6000 c501 system, while FI was analyzed with the Cobas 6000 c601 system. Omentin-1 concentrations were determined using the enzyme-linked immunosorbent assay (ELISA) with a human omentin ELISA kit.</p><p><strong>Results: </strong>FI, HOMA-IR and lipid profiles were significantly elevated in WPS and cessation groups. Omentin-1 and DBP levels significantly decreased in both groups compared to non-smokers. Increased WPS duration leads to reduced BMI, WC and DBP, while cessation duration decreases FBS and SBP. A negative association was identified among omentin-1 with FBS and O<sub>2</sub>.</p><p><strong>Conclusion: </strong>WPS and its cessation adversely affect metabolic health, reducing omentin-1 levels and increasing the risk of metabolic disorders. Over time, cessation improves specific biochemical markers, highlighting the need for public health awareness.</p>","PeriodicalId":8921,"journal":{"name":"Biomarkers","volume":" ","pages":"1-7"},"PeriodicalIF":2.0,"publicationDate":"2025-03-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143623368","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Background: The role of systemic inflammation in the development and progression of cardiovascular diseases has been attractive, but its association with incident dilated cardiomyopathy (DCM) is rarely investigated. This study aimed to systematically investigate the association between various inflammatory markers and DCM incidence.
Methods: The data were derived from the UK Biobank database. Systemic inflammation markers in this study encompassed peripheral immune cell counts and their ratios and the low-grade inflammation score (INFLA-score). The Cox proportional hazards regression, restricted cubic splines model, and segmented regression were adopted to assess the association between systemic inflammation markers and DCM incidence. Additionally, the subgroup Cox analysis stratified across sex was also performed.
Results: A total of 351,148 participants were enrolled in this study, and 377 subjects developed DCM during a mean follow-up of 12.21 years. The positive association between C-reactive protein (CRP), neutrophil-to-lymphocyte ratio (NLR), and CRP-to-lymphocyte ratio (CLR) and DCM incident risk was found (CRP: HR = 1.190, P = 0.001; NLR: HR = 1.315, P = 0.033; CLR: HR = 1.206, P < 0.001), while the lymphocyte-to-monocyte ratio (LMR) was negatively associated with DCM incident risk (HR = 0.756; P = 0.033). Furthermore, the increased risk of DCM incidence was significantly and nonlinearly correlated with the reduction of platelet count (HR = 0.543; P = 0.002). In the subgroup analysis, sex-specific inflammation markers related to DCM development were noticed.
Conclusions: The study has underlined that multiple inflammation markers were significantly associated with the risk of incident DCM, which would provide evidence for the aetiological study of DCM.
{"title":"The association between systemic inflammation markers and the risk of incident dilated cardiomyopathy: a prospective study of 351,148 participants.","authors":"Xihang Fu, Xiaodie Li, Xinxin Gao, Qianlin Zuo, Lin Wang, Hua Peng, Jing Wu","doi":"10.1080/1354750X.2025.2461694","DOIUrl":"10.1080/1354750X.2025.2461694","url":null,"abstract":"<p><strong>Background: </strong>The role of systemic inflammation in the development and progression of cardiovascular diseases has been attractive, but its association with incident dilated cardiomyopathy (DCM) is rarely investigated. This study aimed to systematically investigate the association between various inflammatory markers and DCM incidence.</p><p><strong>Methods: </strong>The data were derived from the UK Biobank database. Systemic inflammation markers in this study encompassed peripheral immune cell counts and their ratios and the low-grade inflammation score (INFLA-score). The Cox proportional hazards regression, restricted cubic splines model, and segmented regression were adopted to assess the association between systemic inflammation markers and DCM incidence. Additionally, the subgroup Cox analysis stratified across sex was also performed.</p><p><strong>Results: </strong>A total of 351,148 participants were enrolled in this study, and 377 subjects developed DCM during a mean follow-up of 12.21 years. The positive association between C-reactive protein (CRP), neutrophil-to-lymphocyte ratio (NLR), and CRP-to-lymphocyte ratio (CLR) and DCM incident risk was found (CRP: HR = 1.190, <i>P</i> = 0.001; NLR: HR = 1.315, <i>P</i> = 0.033; CLR: HR = 1.206, <i>P</i> < 0.001), while the lymphocyte-to-monocyte ratio (LMR) was negatively associated with DCM incident risk (HR = 0.756; <i>P</i> = 0.033). Furthermore, the increased risk of DCM incidence was significantly and nonlinearly correlated with the reduction of platelet count (HR = 0.543; <i>P</i> = 0.002). In the subgroup analysis, sex-specific inflammation markers related to DCM development were noticed.</p><p><strong>Conclusions: </strong>The study has underlined that multiple inflammation markers were significantly associated with the risk of incident DCM, which would provide evidence for the aetiological study of DCM.</p>","PeriodicalId":8921,"journal":{"name":"Biomarkers","volume":" ","pages":"192-199"},"PeriodicalIF":2.0,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143070730","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-03-01Epub Date: 2025-02-14DOI: 10.1080/1354750X.2025.2456023
Panpan Jiang, Kaili Wang, Yaqin Wei, Haonan Chen, Xueqin Cai, Yan Hua, Ming Li
Background: Lung cancer is the cancer with the highest morbidity and mortality in the world. With the increasing diagnosis rate of patients with early-stage lung cancer, surgery treatment becomes an option for more patients. However, there is a lack of effective indicators to assess the risk of recurrence after lung cancer surgery.
Methods: We collected levels of serum autoantibodies and evaluated their roles as biomarkers especially for postoperative recurrence of lung cancer. In vitro experiments including antibody-dependent cellular cytotoxicity (ADCC), antibody-dependent cellular phagocytosis (ADCP) and complement-dependent cytotoxicity (CDC) were performed to explore the functions of serum autoantibodies.
Results: Our study demonstrated that serum autoantibody-positive patients with early-stage lung cancer had a longer postoperative progression period. The levels of serum autoantibodies in patients with lung cancer were higher than that in patients with benign lung diseases. But all the serum autoantibodies had no difference between patients with stage I and II. In addition, the results of in vitro experiments indicated that serum autoantibodies can mediate immune responses and enhance anti-tumour effects.
Conclusion: This study proposed effective biomarkers for prognosis in lung cancer patients after surgery which is critical to reduce the recurrence.
{"title":"Serum autoantibody-based biomarkers for prognosis in early-stage lung cancer patients with surgical resection.","authors":"Panpan Jiang, Kaili Wang, Yaqin Wei, Haonan Chen, Xueqin Cai, Yan Hua, Ming Li","doi":"10.1080/1354750X.2025.2456023","DOIUrl":"10.1080/1354750X.2025.2456023","url":null,"abstract":"<p><strong>Background: </strong>Lung cancer is the cancer with the highest morbidity and mortality in the world. With the increasing diagnosis rate of patients with early-stage lung cancer, surgery treatment becomes an option for more patients. However, there is a lack of effective indicators to assess the risk of recurrence after lung cancer surgery.</p><p><strong>Methods: </strong>We collected levels of serum autoantibodies and evaluated their roles as biomarkers especially for postoperative recurrence of lung cancer. In vitro experiments including antibody-dependent cellular cytotoxicity (ADCC), antibody-dependent cellular phagocytosis (ADCP) and complement-dependent cytotoxicity (CDC) were performed to explore the functions of serum autoantibodies.</p><p><strong>Results: </strong>Our study demonstrated that serum autoantibody-positive patients with early-stage lung cancer had a longer postoperative progression period. The levels of serum autoantibodies in patients with lung cancer were higher than that in patients with benign lung diseases. But all the serum autoantibodies had no difference between patients with stage I and II. In addition, the results of in vitro experiments indicated that serum autoantibodies can mediate immune responses and enhance anti-tumour effects.</p><p><strong>Conclusion: </strong>This study proposed effective biomarkers for prognosis in lung cancer patients after surgery which is critical to reduce the recurrence.</p>","PeriodicalId":8921,"journal":{"name":"Biomarkers","volume":" ","pages":"131-139"},"PeriodicalIF":2.0,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142999504","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Introduction: Elevated fluoride (F-) exposure during childhood produces dental fluorosis (DF). Nails have been used for monitoring systemic F- in relation to DF. The aim of this study was to evaluate F- levels in toenails in association with DF severity in Mexican schoolchildren.
Materials and methods: 120 schoolchildren from nonendemic areas (NEAs) and endemic F- areas (EAs) were screened for DF via the Thylstrup and Fejerskov index (TFI). Toenails were collected to quantify systemic F-. The associations between the biomarker, DF severity, tap water intake, sex, and age were analyzed.
Results: The mean F- in toenails in the NEAs and EAs were 0.63 ± 0.43 and 2.72 ± 1.38 mg/kg, respectively (p < 0.001). A positive correlation was observed between the biomarker and DF severity (rs = 0.755, p < 0.001). Tap water consumption and the biomarker were associated with DF severity (p < 0.001). Within TFI7-8 the mean F- level was higher in those ages 10-11 than in those ages 8-9 (p < 0.05).
Conclusion: Systemic F- levels in toenails are associated with DF severity in Mexican schoolchildren from both the NEAs and the EAs, which reflects the ability of the biomarker to accurately record the exposure to the compound in relation to clinical damage.
{"title":"Systemic fluoride levels in toenails as biomarkers of exposure and their association with the severity of dental fluorosis in Mexican schoolchildren - a cross-sectional study.","authors":"Jesús Lavalle-Carrasco, Nelly Molina-Frechero, Elizabeth Hernández-Pérez, Leonor Sánchez-Pérez, Sandra López-Verdín, Ronell Bologna-Molina","doi":"10.1080/1354750X.2025.2456657","DOIUrl":"10.1080/1354750X.2025.2456657","url":null,"abstract":"<p><strong>Introduction: </strong>Elevated fluoride (F<sup>-</sup>) exposure during childhood produces dental fluorosis (DF). Nails have been used for monitoring systemic F<sup>-</sup> in relation to DF. The aim of this study was to evaluate F<sup>-</sup> levels in toenails in association with DF severity in Mexican schoolchildren.</p><p><strong>Materials and methods: </strong>120 schoolchildren from nonendemic areas (NEAs) and endemic F<sup>-</sup> areas (EAs) were screened for DF via the Thylstrup and Fejerskov index (TFI). Toenails were collected to quantify systemic F<sup>-</sup>. The associations between the biomarker, DF severity, tap water intake, sex, and age were analyzed.</p><p><strong>Results: </strong>The mean F<sup>-</sup> in toenails in the NEAs and EAs were 0.63 ± 0.43 and 2.72 ± 1.38 mg/kg, respectively (p < 0.001). A positive correlation was observed between the biomarker and DF severity (r<sub>s</sub> = 0.755, p < 0.001). Tap water consumption and the biomarker were associated with DF severity (p < 0.001). Within TFI7-8 the mean F<sup>-</sup> level was higher in those ages 10-11 than in those ages 8-9 (p < 0.05).</p><p><strong>Conclusion: </strong>Systemic F<sup>-</sup> levels in toenails are associated with DF severity in Mexican schoolchildren from both the NEAs and the EAs, which reflects the ability of the biomarker to accurately record the exposure to the compound in relation to clinical damage.</p>","PeriodicalId":8921,"journal":{"name":"Biomarkers","volume":" ","pages":"140-146"},"PeriodicalIF":2.0,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143439765","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}